![](https://i-invdn-com.investing.com/news/Moderna_800x533_L_1597823733.jpg)
Moderna stock plunges as guidance cut on low EU sales, U.S. vaccine competition
(Updated - August 1, 2024 9:51 AM EDT) Moderna (NASDAQ:MRNA) reported its second-quarter earnings Thursday, revealing a revenue of $241 million, a significant beat compared to the analyst consensus estimate of $128.41 million. However, the company's …